Unpublished conference/Abstract (Scientific congresses and symposiums)
Characterization of a broad-spectrum hemp extract: analytical quantification of cannabinoids and terpenes and biological evaluation against triple-negative breast cancer cells
Hamann, Carla; Teilliez, Lucas; Jansen, Olivia et al.
2025PSE meeting 2025 : Phytochemicals as Drugs, Foods and Biocommunicators
Peer reviewed
 

Files


Full Text
Abstract oral communication Hamann Carla.docx
Publisher postprint (27.84 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] Triple-negative breast cancer (TNBC) remains a major therapeutic challenge due to its aggressiveness and limited treatment options. Cannabis sativa L. has gained increasing interest for its potential anticancer properties, notably through the potential of cannabinoids and terpenes1. In this study, we developed and characterized a custom-formulated hemp extract (Felina 32 variety) designed to obtain a rich phytochemical composition, with high levels of cannabidiol (CBD) and terpenes, based on our previous research on synergistic interactions to enhance the entourage effect2. This work aimed to evaluate the impact of this extract on the growth of TNBC cells and its potential impact on lymphangiogenesis. Cannabinoid content was quantified using a validated HPLC method, while terpenes profiles were analyzed by GC, with quantitative assessment of key constituents. Antiproliferative effects were monitored kinetically over 72 hours using live-cell imaging (Incucyte SX-5, Sartorius). The extract significantly inhibited the growth of MDA-MB-231 cells, with a growth rate value of 0.18 ± 0.06 at 72 hours, indicating a near-cytostatic activity compared to control cells (GR = 1.00). Holotomographic microscopy (CX-A, Nanolive) revealed clear morphological alterations in response to treatment (loss of adherence and formation of apoptotic bodies), providing dynamic insights into cellular responses. Given the established role of lymphangiogenesis in TNBC metastasis3, additional tests were conducted on lymphatic endothelial cells (LEC) to investigate the influence of the extract on these cells. Reduction in LEC proliferation and morphological alterations were observed. Preliminary toxicity screening was performed using zebrafish embryo models to evaluate safety profiles. These findings support the therapeutic potential of optimized hemp extracts for TNBC management and highlight the importance of preserving the complete phytochemical profile to harness potential synergistic effects.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Hamann, Carla  ;  Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Teilliez, Lucas ;  Université de Liège - ULiège > Faculté de Médecine > Master sc. pharma., fin. approf.
Jansen, Olivia ;  Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Jullien, Kateline  ;  Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Ledoux, Allison  ;  Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Maquoi, Erik  ;  Université de Liège - ULiège > GIGA > GIGA Cancer - Tumors Biology and Development
Frederich, Michel  ;  Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Language :
English
Title :
Characterization of a broad-spectrum hemp extract: analytical quantification of cannabinoids and terpenes and biological evaluation against triple-negative breast cancer cells
Alternative titles :
[fr] Caractérisation d’un extrait de chanvre à large spectre : quantification analytique des cannabinoïdes et des terpènes et évaluation biologique sur des cellules de cancer du sein triple négatif
Publication date :
22 October 2025
Event name :
PSE meeting 2025 : Phytochemicals as Drugs, Foods and Biocommunicators
Event organizer :
Phytochemical Society of Europe
Event place :
Madeira, Portugal
Event date :
22-24 octobre 2025
Event number :
OC:13
Audience :
International
Peer review/Selection committee :
Peer reviewed
Available on ORBi :
since 02 June 2026

Statistics


Number of views
16 (1 by ULiège)
Number of downloads
0 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi